Ekin Soydan

Dr. Ekin Soydan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2021 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
GCGokhan Ceylan
Gokhan Ceylan
STSevgi Topal
Sevgi Topal
GAGulhan Atakul
Gulhan Atakul
MCMustafa Colak
Mustafa Colak
ESEkin Soydan
Ekin Soydan
HAHasan Ağın
Hasan Ağın

4 October 2023 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
ESEkin Soydan
Ekin Soydan
MMMehmet Murat
Mehmet Murat
CKCeren Karahan
Ceren Karahan
AGAhmet Gonullu
Ahmet Gonullu
YAYigit Aksoy
Yigit Aksoy
HAHasan Agın
Hasan Agın

21 September 2022 in Journal of Child Neurology
Verified
Journal Article
Closed access
ESEkin Soydan
Ekin Soydan
AGAhmet Gonullu
Ahmet Gonullu
YAYigit Aksoy
Yigit Aksoy
YGYigithan Guzin
Yigithan Guzin
GCGokhan Ceylan
Gokhan Ceylan
HAHasan Agın
Hasan Agın
Objective: To prospectively investigate the predictive value of the modified Status Epilepticus Severity Score (STESS) for pediatric use (STEPSS) regarding unfavorable outcomes in the short term. Methods: Patients diagnosed as status epilepticus in the emergency department between January 2019 and June 2021 at a tertiary center of the University of Health Sciences, Dr. Behcet Uz Children's Hospital, were included in the study. The patients were followed up in the emergency department, neurology clinic, and pediatric intensive care unit until discharge. Demographic and clinical characteristics, STEPSS, and Pediatric Overall Performance Category Scale (POPC) scores were calculated. We defined a Pediatric Overall Performance Category Scale score ≥3 as an unfavorable outcome. We compared the effect of STEPSS on unfavorable outcomes and mortality. Results: 124 children were included. The median age was 33 months (interquartile range 16.2-84.7). Seventy-two (58.1%) patients had acute symptomatic etiology. We found that the STEPSS score with the receiver operating characteristic curve (area under the curve = 0.917, P < .001) could predict unfavorable outcomes (Pediatric Overall Performance Category Scale score ≥3) in children with status epilepticus. The Youden index (0.76) showed that a STEPSS score >2 was the optimal cutoff point for an unfavorable outcome. We found STEPSS useful in predicting mortality (area under the curve = 0.853, P < .001). The Youden index (0.58) indicated that a STEPSS >2 was the optimal cutoff for mortality: sensitivity 0.90 (95% confidence interval [CI] 0.58-0.99), specificity 0.67 (95% CI 0.57-0.77), positive predictive value 0.21, negative predictive value 0.98, positive likelihood ratio 2.7, negative likelihood ratio 0.14. Conclusion: We determined that STEPSS can be predicted unfavorable outcomes and mortality. We think that STEPSS can be used as a useful clinical score with further studies and external validations.

1 January 2022 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
OSOzlem Sarac
Ozlem Sarac
GCGokhan Ceylan
Gokhan Ceylan
FSFerhat Sari
Ferhat Sari
GAGülhan Atakul
Gülhan Atakul
MCMustafa Colak
Mustafa Colak
HAHasan Ağin
Hasan Ağin
Background/aim: Hyperlactatemia is a common finding in critically ill patients and has significant prognostic implications. However, a single lactate measurement has not been correlated to mortality consistently. In this study, we aimed to correlate the clinical efficacy of lactate clearance for the prediction of mortality in pediatric intensive care unit patients. Materials and methods: This retrospective observational study was performed in the pediatric intensive care unit in patients with lactate level >3 mmol/lt. Initial, 6th h, and 24th h lactate levels were recorded and lactate clearance was calculated using these values (lactate level at admission - level 6 h later × 100/lactate level at admission). Results: A total of 172 patients were included in the study. Forty-four out of 172 patients died. Median (IQR) lactate (mmol/L) at admission was low in those who survived in comparison to nonsurvivors 4.4 (3.1) vs. 5.75 (7.7) (p = 0.002). Clearance at 6th h was significantly lower in those who died (11.7%) than those who survived (36.7) (p = 0.001). 6th h lactate clearance level <20.7% predicted mortality with a sensitivity of 63.6% and specificity of 69.5% along with a positive predictive value of 41.8 and a negative predictive value of 84.8 (p = 0.004). Both lactate levels and lactate clearance values were significantly predictive factors for mortality (p < 0.05). Only a positive moderate correlation was found between the percentage of PRISM-IV % and 6th h lactate level. Conclusion: The present study revealed that lactate clearance is a simple and rapid risk-stratification tool holding to be a potential biomarker of managing the treatment efficacy of children in the pediatric intensive care unit.


26 February 2024 in Istanbul Medical Journal
Verified
Journal Article
Closed access
MCMustafa Colak
Mustafa Colak
GCGokhan Ceylan
Gokhan Ceylan
STSevgi Topal
Sevgi Topal
OSOzlem Sarac
Ozlem Sarac
GAGülhan Atakul
Gülhan Atakul
HAHasan Ağın
Hasan Ağın